Skin & hair

The Antifungal Pills and When You Need One

Save

Not every fungal rash responds to a drugstore cream, and knowing when a pill is actually warranted, rather than reached for out of impatience, matters. Oral antifungals carry considerations a cream doesn't. Terbinafine and itraconazole aren't interchangeable: they target different fungi, clear the body on different timelines, and get chosen for different situations, from a child's scalp ringworm to a resistant infection that outlasted everything else.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When Does a Fungal Infection Need a Pill Instead of a Cream?

Topical antifungal creams clear most ringworm, athlete's foot, and jock itch on their own — ringworm is a common dermatophyte skin infection, spread by contact with an infected person, animal, or surface, that shows up as a circular, scaly rash 1. But a few situations call for an oral antifungal instead: infections in the scalp or nails, where a cream can't penetrate deeply enough to reach fungus living in the hair shaft or under the nail plate, and infections covering a large area of skin or that haven't cleared after several weeks of consistent topical use. Some ringworm resolves with an over-the-counter topical; other forms, especially on the scalp, need a prescription oral antifungal from the start 2.

Scalp ringworm (tinea capitis) is the clearest example. Because the fungus infects the hair follicle itself, a cream applied to the scalp surface essentially never clears it, and oral treatment is considered necessary rather than optional, particularly in children 3. Toenail and fingernail fungal infections (onychomycosis) sit in a similar category: the fungus lives within and under a dense nail plate that a topical cannot reach in sufficient concentration for most cases. Widespread body ringworm, or a rash that keeps spreading despite weeks of a properly applied cream, rounds out the other common oral antifungal indications. The antifungal creams, weakest to strongest, still hold the line for the vast majority of localized skin infections. Oral treatment is reserved for the situations described above — when antifungal cream fails and dermatophyte treatment escalation becomes the right call.

Terbinafine and Itraconazole Work on Fungus Differently

Terbinafine and itraconazole are both oral antifungals, but they belong to different drug classes and interrupt fungal growth at different points, which is part of why they aren't interchangeable. Terbinafine is an allylamine that blocks an enzyme fungi need to build their own cell membrane; itraconazole is a triazole that blocks a related but distinct enzyme earlier in the same pathway.

The practical difference shows up in which organisms each drug reaches well. Terbinafine is strongly active against dermatophytes — the group of fungi (Trichophyton, Microsporum, Epidermophyton species) responsible for ringworm, athlete's foot, jock itch, and most scalp and nail infections — which is why it's usually the default oral choice for those. Itraconazole has a broader spectrum that extends to yeasts and some molds in addition to dermatophytes, which makes it the more versatile option when the infection isn't a straightforward dermatophyte, or when the specific organism hasn't been pinned down yet. Neither drug is simply "stronger" than the other in a blanket sense; the right choice depends on which fungus is actually involved, which is one reason a clinician may want a scraping sent for microscopy or culture before starting either one, rather than treating on appearance alone.

Why Terbinafine Isn't the Right Choice for Every Fungal Rash

One gap in terbinafine's coverage is worth calling out directly: it does not work against tinea (pityriasis) versicolor, the common yeast infection that causes scaly, discolored patches on the chest, back, and shoulders. That infection is caused by Malassezia, a yeast rather than a dermatophyte, and it falls outside terbinafine's spectrum entirely.

Tinea versicolor is usually treated first with topical antifungals, and when oral therapy is needed — because the rash is extensive, recurrent, or not responding to topical treatment — that means an oral azole such as itraconazole, not terbinafine, since oral terbinafine has been shown to be ineffective for this particular infection 4. This is a useful example of why the two drugs aren't simply ranked strong-to-weak: someone prescribed itraconazole instead of terbinafine hasn't necessarily been given the more powerful option, they've been matched to a fungus terbinafine doesn't reliably treat. Choosing between the two is a matter of matching drug to organism, not picking whichever pill sounds more potent.

Scalp Ringworm in Children: A Case Where the Choice Is Actually Studied

Tinea capitis, the scalp ringworm that mostly affects children, is one of the better-studied head-to-head comparisons between oral antifungal options. A Cochrane systematic review found that both oral terbinafine and griseofulvin, an older oral antifungal, are effective treatments for tinea capitis in children, with the better option depending on which organism is causing the infection 3.

Terbinafine tends to work better against Trichophyton species, which are now the more common cause of tinea capitis in much of the United States, while griseofulvin performs better against Microsporum species 3. Itraconazole is generally kept as an alternative for cases where these two standard options underperform, or where resistance is suspected. Because the organism drives the answer more than the diagnosis alone does, a clinician confirming tinea capitis will often want to know, or test, which fungal species is involved before settling on a specific oral antifungal — the same species-matching logic that applies to the terbinafine-versus-itraconazole decision generally.

When Resistance Enters the Picture

A newer complication in this decision is the emergence of antifungal-resistant strains of Trichophyton — dermatophytes that no longer respond reliably to a standard oral terbinafine course. Clinical guidance now flags this resistance as a reason some ringworm infections require itraconazole or referral to a specialist, rather than a straightforward course of terbinafine 5.

This matters most for infections that don't improve after a full course of an oral antifungal that would normally be expected to work, or for people who have recently traveled to, or have close contacts in, regions where these resistant strains have been reported. In that situation, a clinician may switch antifungal classes, repeat testing to confirm the organism, or refer to a dermatologist experienced with resistant dermatophyte infections, rather than simply repeating the same drug. It's a reminder that a fungal infection that isn't clearing on schedule is worth going back to a clinician about, rather than assuming the diagnosis is wrong or the infection is just stubborn.

What the Choice Usually Comes Down To

In practice, the decision between terbinafine and itraconazole rests on the specific organism involved, the site of infection, and a person's own health history, rather than a fixed rule that one drug is always preferred. Confirming the diagnosis — often with a skin scraping examined under a microscope or sent for fungal culture — is what lets a clinician match the drug to the fungus rather than guess.

Both oral antifungals are processed by the liver, so a clinician will typically ask about liver disease, current medications, and alcohol use before prescribing either, since drug interactions and liver considerations differ between the two classes. Treatment courses also run longer for nail infections than for skin or scalp infections, simply because a nail grows out slowly and the infected portion has to grow out before the new nail looks clear. None of this needs to be sorted out alone — a clinician who can examine the affected skin, hair, or nail and confirm the organism is the one positioned to weigh these considerations.

Common questions

Not in a simple sense — the two drugs work against different fungi rather than sitting on a strong-to-weak scale. Terbinafine is usually favored for dermatophyte infections like ringworm, while itraconazole covers a broader range including certain yeasts. Being prescribed itraconazole usually means the infection calls for its broader coverage, not that terbinafine failed to work hard enough.

Confirming which fungus is actually involved, often through a scraping examined under a microscope or sent for culture, lets a clinician match the drug to the organism rather than guess. Since terbinafine and itraconazole cover different fungi, treating without confirming the cause risks weeks on the wrong drug before anyone notices it isn't working.

Generally not. Tinea versicolor is caused by a yeast, not the dermatophyte fungi terbinafine targets, so oral terbinafine typically does not clear it. Extensive or recurrent tinea versicolor that needs oral treatment is usually treated with an oral azole such as itraconazole instead, alongside topical antifungals.

Oral antifungal courses for nail infections run considerably longer than for skin or scalp infections, since a nail grows out slowly and the already-infected portion has to grow out before the nail looks clear. That's a structural reality of how nails grow, not a sign the medication is failing partway through.

A rash that doesn't improve on schedule is worth bringing back to a clinician rather than assuming the infection is simply stubborn. Emerging antifungal-resistant strains of the fungi that cause ringworm are one reason a case might need itraconazole, further testing, or a specialist referral instead of repeating the same course.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a Fungal Infection Needs a Closer Look

  • —A rash, scalp infection, or nail infection that hasn't improved after a full course of a properly taken oral antifungal
  • —Spreading redness, warmth, swelling, or pus around a fungal rash, which can signal a bacterial infection on top of the fungal one
  • —Hair loss with scarring, or scalp swelling and tenderness, alongside suspected scalp ringworm
  • —Yellowing of the skin or eyes, dark urine, or persistent nausea while taking an oral antifungal

This article is general health information, not medical advice. It cannot diagnose a fungal infection or determine which oral antifungal, if any, is right for you. A clinician who can examine the affected skin, hair, or nail and confirm the organism involved is the right source for that decision.

References

  1. 1.Centers for Disease Control and Prevention (2024). Ringworm Basics. CDC. linkRingworm is a common dermatophyte skin infection, spread by contact with infected people, animals, or surfaces, presenting as a circular, scaly rash.
  2. 2.Centers for Disease Control and Prevention (2024). Treatment of Ringworm. CDC. linkSome ringworm can be treated with over-the-counter topical antifungals, while other forms, particularly scalp ringworm, require a prescription oral antifungal.
  3. 3.Chen X, Jiang X, Yang M, et al. (2016). Systemic antifungal therapy for tinea capitis in children. Cochrane Database of Systematic Reviews. PMID 27816294 ✓Oral terbinafine and griseofulvin are both effective for tinea capitis in children, with terbinafine favored for Trichophyton infections and griseofulvin favored for Microsporum infections; oral treatment is required because topical therapy cannot reach the infected hair follicle.
  4. 4.Leung AKC, Barankin B, Lam JM, et al. (2023). Pityriasis Versicolor—A Narrative Review on the Diagnosis and Management. Cureus / PMC. PMID 37895478 ✓Pityriasis (tinea) versicolor is a Malassezia yeast infection treated first-line with topical antifungals, with oral azoles used for extensive or recurrent disease; oral terbinafine is not effective for this infection.
  5. 5.Centers for Disease Control and Prevention (2024). Clinical Overview of Ringworm. CDC. linkNotes the emergence of antifungal-resistant Trichophyton species that may require itraconazole or specialist management rather than a standard oral terbinafine course.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library